AVTR Form 144: Restricted Stock Vesting and Proposed Insider Sale
Rhea-AI Filing Summary
Form: Form 144 notice relating to Avantor, Inc. (Issuer stated: Avantor Inc).
Transaction: Proposed sale of 3,476 common shares through Merrill (address: 8890 Lyra Drive 5th Floor Columbus OH 43240) with an aggregate market value of $39,592.00. Approximate sale date is 08/05/2025 on the NYSE. Total shares outstanding reported: 681,738,675.
Acquisition: 1,033 shares were acquired via a Restricted Stock Grant Vest from Avantor Inc on 07/31/2025 with payment dated 07/31/2025. The filer reports Nothing to Report for securities sold in the past three months. Several filer identification/contact fields (e.g., CIK) are blank in the provided extract.
Positive
- Rule 144 disclosure submitted detailing broker, class, quantity, value, and expected sale date
- No securities sold in the past three months reported for the selling person
Negative
- Filer identification/contact fields are blank in the provided extract (e.g., CIK not shown)
- Sale size is small relative to outstanding shares (3,476 vs. 681,738,675), indicating immateriality to capitalization
Insights
TL;DR: Routine Rule 144 disclosure for a small proposed sale; no earnings or guidance impact evident.
The Form 144 reports a proposed sale of 3,476 common shares valued at $39,592, with an approximate sale date of 08/05/2025 on the NYSE. The filing includes acquisition details showing 1,033 shares vested from a restricted stock grant on 07/31/2025. Given the issuer's reported 681,738,675 shares outstanding, the sale size is immaterial to capital structure and does not present a quantifiable impact on revenue, EPS, or market capitalization from the information provided.
TL;DR: Compliance filing completed, but certain filer identification fields are missing in the extract provided.
The notice satisfies Rule 144 disclosure by listing broker, class, quantities, acquisition method, and approximate sale date. The filing extract lacks visible filer CIK and submission contact details, which are typically required for full traceability and regulatory cross-reference. The document also states Nothing to Report for prior three-month sales, which clarifies recent activity. From a governance/compliance view, the missing filer identifiers in this extract warrant completion for full regulatory compliance verification.
FAQ
What does Avantor (AVTR) report in this Form 144?
Who is the broker handling the proposed sale for AVTR?
When and how were the securities acquired for this AVTR sale?
Does the filing show any sales in the past three months for the seller?
How large is the proposed sale relative to Avantor's outstanding shares?
Are any filer identification details missing from the provided extract?